-

NEW PAIN MED IS AS EFFECTIVE AS OPIOIDS





 Cannabis-based pain medications are starting to make real waves as alternatives to the usual painkillers, especially opioids. 

One name you might hear more about soon is MIRA, a compound pulled from cannabis that’s getting a lot of interest for how it handles pain differently. MIRA-55, in particular, stands out—it isn’t just another version of THC (the stuff in cannabis that gets you high). Its structure is unique, and it works in a completely different way. Instead of hitting the CB1 receptor hard like THC does (which is what causes that classic cannabis “high”), MIRA-55 targets pain without leaving patients feeling out of it. That’s a big deal for people who need relief but don’t want the head rush or mental fog that can come with medical cannabis (mirapharmaceuticals.com).

What’s really interesting is what the research is starting to show. People with chronic pain who try cannabis-based treatments often report not just less pain, but better quality of life—and, in some cases, they end up cutting back on other pain meds, including opioids (PLOS ONE; Frontiers in Pharmacology). One early study even found that some patients swapped out their usual prescriptions for cannabis on their own, hinting that it might be a real option for tough cases like neuropathic pain (Frontiers in Pain Research).

Of course, no medication is perfect, and cannabis-based drugs like MIRA-55 aren’t for everyone. There can be side effects, and doctors are still determining the full implications of long-term safety. But early signs are promising: MIRA-55 seems to deliver pain relief without the heavy psychoactive effects you’d get from traditional THC products (mirapharmaceuticals.com).

In short, MIRA is part of a new direction in pain management—one that’s all about finding relief without the unwanted “high.” As more research rolls in, these kinds of medications could become go-to options for people looking to get off opioids or for those who don’t want the mind-bending effects of THC.

Comments

Post a Comment

Popular posts from this blog

-
Image
DIABETES: UNDERSTANDING THIS CONDITION   Diabetes is a complex, chronic condition that comes in several forms, each with its own causes, risks, and best ways to manage it.  Diabetes alters how your body uses insulin, a substance produced in the pancreas, required by cells to absorb sugar in the form of glycogen. When glycogen is unavailable to your cells, they lack an energy source. The two most common types of Diabetes are Type 1 and Type 2 diabetes. Type 1 is primarily an autoimmune issue—your own immune system mistakenly destroys the insulin-producing cells in your pancreas (Nature Reviews Disease Primers) There are also rare, less-understood forms, often linked to genetics. Type 2 diabetes, which accounts for over 90% of all cases, develops when your body becomes resistant to insulin or doesn't make enough of it (Nature Reviews Disease Primers; NY.gov). Symptoms can be similar to those of Type 1, but often develop more gradually and may also include blurred vision, slow-he...
Read more
-
Image
COLONOSCOPY: WHAT YOU NEED TO KNOW A colonoscopy remains one of the most effective ways to detect and prevent colorectal cancer before it becomes a serious threat. During the procedure, doctors can find and remove precancerous polyps, significantly lowering your chances of developing colorectal cancer later on. Studies consistently show that getting a colonoscopy every 10 years—recommended for most adults at average risk—not only saves lives but also costs less over time compared to other screening methods, such as yearly fecal occult blood tests (FOBTs) (Annals of Internal Medicine). Medical experts generally recommend starting regular colonoscopy screenings around age 45 or 50, depending on your health history, and repeating them every 10 years if no issues are found. This timeline is supported by substantial evidence showing colorectal cancer rates stay very low within ten years of a clean colonoscopy (BMJ). If colorectal cancer or certain polyps run in your family, your doctor migh...
Read more

Diabetes drugs may reduce the risk of Alzheimer’s.

-
Image
    Diabetes drugs may reduce the risk of Alzheimer’s. The study finds people taking the drugs have fewer biomarkers, slower cognitive decline. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer's disease compared to people with type 2 diabetes who are not taking the drugs and those without diabetes. The new study, published in the August 11, 2021, online issue of  Neurology , the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups. In people with type 2 diabetes, the body no longer efficiently uses insulin to control blood sugar. Dipeptidyl peptidase-4 inhibitors, also known as gliptins, can be prescribed when other diabetes drugs do not work. They help control blood sugar when combined with diet and exercise. "People with diabetes have been shown to ...
Read more